TrialThe Journal of clinical investigation2014

Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma.

Jihun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.